Treatment options for atopic dermatitis
- PMID: 17323714
Treatment options for atopic dermatitis
Abstract
Atopic dermatitis is a common inflammatory skin condition that usually affects children. It is a chronic disease, with periods of remission and flare-ups, that adversely affects the quality of life of patients and their families. Aggressive therapy with emollients is an important intervention for patients with atopic dermatitis. Patients should avoid individual disease triggers and allergens. Topical corticosteroids are the mainstay of treatment for flare-ups and are the standard to which other treatments are compared. Topical calcineurin inhibitors should not be used in patients younger than two years or in those who are immunosuppressed, and should be secondline therapies in other patients. Rarely, systemic agents (e.g., cyclosporine, interferon gamma-1b, oral corticosteroids) may be considered in adults.
Similar articles
-
Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.Pediatrics. 2007 Sep;120(3):e527-34. doi: 10.1542/peds.2007-0289. Pediatrics. 2007. PMID: 17766497
-
Atopic dermatitis: an overview.Am Fam Physician. 2012 Jul 1;86(1):35-42. Am Fam Physician. 2012. PMID: 22962911 Review.
-
Topical treatment of atopic dermatitis.Immunol Allergy Clin North Am. 2004 Nov;24(4):631-44, vi-vii. doi: 10.1016/j.iac.2004.06.011. Immunol Allergy Clin North Am. 2004. PMID: 15474863 Review.
-
[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].Pol Merkur Lekarski. 2004;17 Suppl 3:3-15. Pol Merkur Lekarski. 2004. PMID: 15688665 Review. Polish.
-
Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis.Clin Pediatr (Phila). 2008 May;47(4):332-46. doi: 10.1177/0009922807309421. Epub 2007 Dec 5. Clin Pediatr (Phila). 2008. PMID: 18057146
Cited by
-
Efficacy of a Multi-lamellar Emulsion Containing a Synthetic Sphingosine Kinase 1 Activator and Pseudoceramide in Patients with Atopic Dermatitis: A Randomized Controlled Trial.Dermatol Ther (Heidelb). 2024 Sep;14(9):2591-2605. doi: 10.1007/s13555-024-01254-5. Epub 2024 Aug 30. Dermatol Ther (Heidelb). 2024. PMID: 39212849 Free PMC article.
-
Novel Vehicles For Drug Delivery in Atopic Dermatitis: A Narrative Review.Dermatol Pract Concept. 2023 Oct 1;13(4):e2023216. doi: 10.5826/dpc.1304a216. Dermatol Pract Concept. 2023. PMID: 37992345 Free PMC article. Review.
-
Health-Related Behaviors and Psychological Status of Adolescent Patients with Atopic Dermatitis: The 2019 Korea Youth Risk Behavior Web-Based Survey.Patient Prefer Adherence. 2023 Mar 18;17:739-747. doi: 10.2147/PPA.S406125. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 36970303 Free PMC article.
-
The Contest of Nanoparticles: Searching for the Most Effective Topical Delivery of Corticosteroids.Pharmaceutics. 2023 Feb 3;15(2):513. doi: 10.3390/pharmaceutics15020513. Pharmaceutics. 2023. PMID: 36839836 Free PMC article.
-
Analisi costo-utilità di dupilumab per il trattamento della dermatite atopica grave negli adulti in Italia.Glob Reg Health Technol Assess. 2020 Aug 24;7:57-65. doi: 10.33393/grhta.2020.710. eCollection 2020 Jan-Dec. Glob Reg Health Technol Assess. 2020. PMID: 36627954 Free PMC article. Italian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
